Integration of Science, Technology Key to Battelle’s New Molecular Imaging Services

Battelle, the world’s largest independent research and development organization, continues to advance human health with its new, comprehensive Molecular Imaging Solutions portfolio. Battelle uniquely combines the engineering, scientific and diagnostic proficiency of its medical device experts with industry-leading life science capabilities to deliver highly differentiated services. This gives manufacturers an integrated solution from a single service provider across the broad spectrum of molecular imaging needs, including: • Molecular targets (gene expression profiling, proteomics) • Chemistry (nanoparticles, combinatorial chemistry) • Molecular/cellular biology (cell delivery, spatial localization of targets) • Biomarker development and validation • Nonclinical imaging (equipment development, pharmacokinetics, toxicology) • Computer modeling (image reconstruction, statistical analysis) • Clinical imaging equipment development (controlled delivery RP power injectors, scanners, cameras, RP generator/synthesizer) • Medical isotope testing laboratory and radioactive material (RAM) license “The unique ability to draw from the collective experience and expertise across Battelle’s vast network of science and technology disciplines for improved imaging services allows us to advance human health and to boost our clients’ product-development pipelines,” said Barbara Kunz, president of Battelle’s Health and Life Sciences Global Business. Battelle will feature its innovative new molecular imaging services at booth No. 3026 at the Society of Nuclear Medicine Annual Conference, June 4-6, in San Antonio, Texas. “Battelle’s expert teams in medical devices and diagnostics; safety and efficacy testing; and biomarkers and assay development work together to dramatically improve imaging services to advance human health,” said Chad Bouton, research leader. About Battelle As the world’s largest, independent research and development organization, Battelle provides innovative solutions to the world’s most pressing needs through its four global businesses: Health and Life Sciences; Laboratory Management; National Security;; and Energy, Environment and Material Sciences. It advances scientific discovery and application by conducting $6.5 billion in global R&D annually through contract research and development, laboratory management and technology commercialization. Headquartered in Columbus, Ohio, Battelle oversees 22,000 employees in more than 130 locations worldwide, including seven national laboratories which Battelle manages or co-manages for the U.S. Department of Energy and the U.S. Department of Homeland Security and a nuclear energy lab in the United Kingdom. For more information, contact Katy Delaney at (614) 424-7208 or delaneyk@battelle.org or T.R. Massey at (614) 424-5544 or masseytr@battelle.org.